One of the most common somatic mutations occurring in glioma involve isocitrate dehydrogenase (IDH) enzymes [44], which are associated with reduced levels of α-ketoglutarate (α-KG) caused by the conversion of α-KG into D-2-hydroglutarate (2-HG) [45,46]. This evidence concerns the gene IDH1 and central nervous system cancer.